News

The biomarkers found during the interruption of ART could help predict HIV remission by providing interpretative clues on the biological mechanisms of HIV duplication after stopping ART, as well as assist in the design of a new way to cure the disease.

This procedure involves endoscopic creation of an antireflux ‘Omega’ valve, showing promise by acting as a durable barrier to reflux and exhibiting fewer symptoms than that seen in traditional fundoplication.

A study upon Pfizer and Moderna vaccines has revealed fewer complications in patients with inflammatory bowel diseases (IBD) compared with the general population.

A study by Kim Papp looked at ruxolitinib as a topical cream for AD. Ruxolitinib works by inhibiting JAK1 and JAK2 on the cell surface and consequently affects the signalling cascade that would eventually produce pro-inflammatory cytokines.

PSORIASIS is a painful inflammatory skin disease that affects approximately 125 million individuals worldwide. Currently, there is no cure for psoriasis.

Hopeful researchers have discovered use of the common antibiotic doxycycline, in combination with TB drug treatment, effective in reducing these lung cavities and accelerating markers of lung recovery.

Research conducted at Massachusetts General Hospital (MGH) has uncovered four subtypes of infection, caused by the bronchiolitis respiratory syncytial virus (RSV), one of which is linked with higher asthma risk.  

Karim Halazun, Associate Professor of Surgery, Weill Cornell Medicine, New York City, New York, USA, and colleagues explored whether the dynamic α-fetoprotein response (AFP-R) could improve pre-operative prediction of patient outcomes.